Figure 3.
Effects of BXDC knockdown on the cytotoxicity of various anti-cancer agents in bladder cancer cells. MTT assay in 5637-control-shRNA vs. 5637-BXDC2-shRNA sublines (A) or UMUC3-control-shRNA vs. UMUC3-BXDC2-shRNA sublines (B) cultured for 72 h in the presence of MTX (0–2.0 µM), VBL (0–20 µM), DOX (0–2.0 µM), or GEM (0–20 µM). Cell viability is presented relative to that of each subline without anti-cancer drug treatment. Each value represents the mean (± SD) from at least 3 determinants.